Worldwide Orthopedic Biomaterials Industry to 2030 - Players Include Zimmer Biomet Holdings, Stryker and Globus Medical Among Others
07 avr. 2021 04h43 HE
|
Research and Markets
Dublin, April 07, 2021 (GLOBE NEWSWIRE) -- The "Orthopedic Biomaterials Global Market Opportunities and Strategies to 2030: COVID-19 Impact and Recovery" report has been added to...
Global Biomaterials Market (2020 to 2025) - by Product, Material Type, Type, Application, End-user and Region
13 nov. 2020 04h23 HE
|
Research and Markets
Dublin, Nov. 13, 2020 (GLOBE NEWSWIRE) -- The "Global Biomaterials Market By Product (Implants, Valves, Joint Replacement, Contact Lenses and Others), By Material Type (Metallic, Natural, Ceramics,...
CURE Pharmaceutical Secures Patent on Oral Thin Film Containing Bioactive Cannabinoid Molecules
22 mai 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the issuance of U.S. Patent No. 10,307,397,...
Emerald Health Therapeutics Closes Emerald Health Naturals Joint Venture
10 janv. 2019 07h00 HE
|
Emerald Health Therapeutics Inc.
VICTORIA, British Columbia, Jan. 10, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV:EMH; OTCQX:EMHTF) is pleased to announce that, further to its news releases dated...
Emerald Health Therapeutics Receives TSX Venture Conditional Approval of Emerald Health Naturals Joint Venture
19 nov. 2018 07h00 HE
|
Emerald Health Therapeutics Inc.
Joint venture to distribute endocannabinoid-supporting products to Canadian natural health product stores and pharmacies VICTORIA, British Columbia, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Emerald...
CURE Pharmaceutical Secures Patent for Oral Thin Film Containing Bioactive Cannabinoid Molecules
25 sept. 2018 08h45 HE
|
CURE Pharmaceutical
LOS ANGELES, Sept. 25, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, announced the allowance of an oral thin film patent (U.S. Patent...
CURE Pharmaceutical Secures Two Patents for the Extraction and Purification of Bioactive Cannabinoid Molecules
04 avr. 2018 08h57 HE
|
CURE Pharmaceutical
LOS ANGELES, April 04, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the acquisition of two patents that ensure CURE...